| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
ProPhase Labs Inc oriented and diversified next generation biotech, genomics and consumer products company that develops and commercializes novel drugs, dietary supplements, and compounds, and human genomic testing. It offer whole genome sequencing...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of PROPHASE LABS INC by ProPhase Labs, Inc. (OTCID:PRPH) through any online brokerage.
There are no as such competitors for PROPHASE LABS INC by ProPhase Labs, Inc..
PROPHASE LABS INC by ProPhase Labs, Inc. has a consensus price target of $110.00.
The stock price for PROPHASE LABS INC by ProPhase Labs, Inc. (OTCID: PRPH) is $0.01565 last updated October 5, 2026 at 9:20 AM EDT.
There are no upcoming dividends for PROPHASE LABS INC by ProPhase Labs, Inc..
PROPHASE LABS INC by ProPhase Labs, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for PROPHASE LABS INC by ProPhase Labs, Inc..
PROPHASE LABS INC by ProPhase Labs, Inc. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCID.
